Pramipexole hydrochloride LA tablets 1.5mg MI “Sawai”, manufactured by Sawai Pharmaceutical, contain pramipexole hydrochloride hydrate. This long-acting formulation, with YJ code 1169012G2075 and a standard of 1.5 mg per tablet, is typically used to manage symptoms of Parkinson’s disease and restless legs syndrome.
Pramipexole hydrochloride LA tablets 1.5mg MI “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
